Sanofi-aventis: Adding Lantus(R) to Oral Antidiabetic Drug Therapy Further Reduced Blood Sugar in Patients With Type 2 Diabetes - Findings Presented at European Association for the Study of Diabetes ...
DA Approves New Route of Administration for Sanofi-Aventis's Rapid-Acting Apidra BRIDGEWATER, N.J., June 15 -- Sanofi-aventis announced today that following a review of a supplemental New Drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results